Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Pulse Biosciences First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Pulse Biosciences Inc. (PLSE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 54,082 | $471,054 | +1362% | 0% |
| 2. | 52,800 | $459,888 | +376% | 0% | |
| 3. | Millennium Management Israel Englander | 41,327 | $359,958 | 0% | |
| 4. | 14,000 | $121,940 | -46% | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 13,500 | $117,585 | -50% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.15 | 17,999 | Large Shareholder, Director | 36,984,179 | 2023-12-12 | Filing | |
| $9.36 | 90,118 | Large Shareholder, Director | 36,966,180 | 2023-12-11 | Filing | |
| $9.54 | 116,656 | Large Shareholder, Director | 36,876,062 | 2023-12-08 | Filing | |
| $9.19 | 74,852 | Large Shareholder, Director | 36,759,406 | 2023-12-07 | Filing | |
| $9.06 | 82,813 | Large Shareholder, Director | 36,684,554 | 2023-12-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.90 | 5,000 | Director | 0 | 2017-05-12 | Filing | |
| $23.90 | 5,000 | Director | 5,000 | 2017-05-12 | Filing | |
| $21.87 | 2,820 | Director | 0 | 2017-05-10 | Filing | |
| $21.03 | 22,180 | Director | 2,820 | 2017-05-10 | Filing | |
| $22.49 | 15,000 | Director | 0 | 2017-05-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,071,736 | $13,118,049 | 0% | |
| 2. | 801,341 | $9,808,415 | 0% | |
| 3. | 657,985 | $8,053,737 | 0% | |
| 4. | 379,259 | $4,642,639 | 0% | |
| 5. | 309,520 | $3,788,525 | 0% |
News See All
5 ChatGPT Penny Stock Picks Right Now
Pulse Biosciences, Inc. (NASDAQ:PLSE) is using its exclusive technologies to treat heart diseases. The stock is up 33% over the past one year. Earlier this month Pulse Biosciences, Inc.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Pulse Biosciences Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Pulse Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
15 Best-Performing Stocks in the Last 12 Months
The US stock market has been performing unusually well in 2023. The most recent catalyst came after the Federal Reserve’s fight against inflation started signs of bearing fruit.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Pulse Biosciences' Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
11 Stocks with Heavy Insider Buying in 2023
Insider trading activity has always invited interest and controversy from investors and authorities.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and thank you for standing by. Welcome to the Pulse Biosciences First Quarter 2023 Earnings Conference Call.
Hedge Fund and Insider Trading News: Paul Tudor Jones, Michael Burry, George Soros, Elliott Investment Management, AQR Capital Management, Protean Select, Callon Petroleum Company (CPE), Pulse Biosciences, Inc. (PLSE), and More
Hedge fund manager Paul Tudor Jones said that bitcoin (BTC) has become less attractive thanks to what's become an unfriendly regulatory picture in the U.S.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings, and welcome to the Pulse Biosciences' Fourth Quarter 2022 Earnings Conference Call. At this time all participants lines are in a listen-only mode.
Billionaire Hedge Funds
